Related Experiment Video
Updated: Jun 26, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Seizure recurrence risk following a first seizure in neurologically normal children
Todd M Arthur1, Ton J deGrauw, Cynthia S Johnson
1Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Insights
Seizure recurrence is common in children after a single unprovoked seizure. While electroencephalography (EEG) is not predictive, magnetic resonance imaging (MRI) may help identify children at higher risk for recurrence.
Area of Science:
- Pediatric Neurology
- Epilepsy Research
Background:
- Recurrence risk after a first afebrile, unprovoked seizure in children is a critical clinical question.
- Understanding predictors of seizure recurrence is essential for guiding treatment decisions.
Purpose of the Study:
- To determine seizure recurrence rates in children experiencing a single seizure.
- To evaluate the predictive utility of electroencephalography (EEG) and magnetic resonance imaging (MRI) for seizure recurrence.
Main Methods:
- A prospective study followed 150 children (6-14 years) with a first afebrile, unprovoked seizure.
- Participants had normal neurological exams and underwent EEG and brain MRI.
- Follow-up extended for a minimum of 27 months.
Main Results:
- The overall seizure recurrence rate was 66.4%.
- Abnormal EEG findings did not correlate with seizure recurrence at any follow-up interval (9, 18, or 27 months).
- Significant MRI abnormalities (16.0% of cases) were associated with increased recurrence risk at 9 months but not later.
Conclusions:
- Electroencephalography (EEG) has limited value in predicting seizure recurrence after a single childhood seizure.
- The high prevalence of MRI abnormalities suggests its potential role as a routine diagnostic tool for evaluating childhood epilepsy.
Purpose:
To define seizure recurrence rates in normal children who had had a single seizure and to define electroencephalography (EEG) or magnetic resonance imaging (MRI) utility in predicting seizure recurrence.
Methods:
We studied 150 children (6 to 14 years) with a first afebrile, unprovoked seizure. Inclusion criteria were: Normal physical and neurological examination, undergone EEG and MRI studies of the brain, and followed for at least 27 months. These children participated in an ongoing prospective study of new onset seizures in childhood.
Results:
The seizure recurrence rate was 66.4%. An abnormal EEG had no association with seizure recurrence at 9, 18, or 27 months (p = 0.1806, p = 0.2792, and p = 0.2379, respectively). A "significant" MRI abnormality, which occurred in 16.0% of patients, was associated with an increased seizure recurrence risk at 9 months (p = 0.0389) but not at 18 or 27 months.
Discussion:
EEG findings poorly predict recurrence after a single seizure. The high rate of MRI abnormalities suggests that MRI may need consideration as a routine test to evaluate epilepsy in normal children.
More Related Videos
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy ll: Types
Seizures l: Introduction
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...